Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 310Lung Neoplasms 71Neoplasms 51Neoplasm Metastasis 34Colorectal Neoplasms 21Carcinoma 21Parkinson Disease 4, Autosomal Dominant Lewy Body 20Mesothelioma 15Breast Neoplasms 15Mesothelioma, Malignant 13Small Cell Lung Carcinoma 11Neoplasms by Site 10Melanoma 10Adenocarcinoma 10Pancreatic Neoplasms 8Adenocarcinoma of Lung 8Ovarian Neoplasms 7Lung Diseases 7Thoracic Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Non-Squamous Non-Small Cell Lung Cancer 6Uterine Cervical Neoplasms 5Respiratory Tract Neoplasms 5Respiratory Tract Diseases 5Recurrence 5Rectal Neoplasms 5Neoplasms by Histologic Type 5NSCLC 5Head and Neck Neoplasms 5Endometrial Neoplasms 5

Interventions

Cisplatin 4Cetuximab 4pembrolizumab 3Radiotherapy 2Pemetrexed 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2monalizumab 1capmatinib 1Vitamin B 12 1Tirapazamine 1Tablets 1Radiotherapy, Intensity-Modulated 1LY2940680 1Folic Acid 1Fibroblast Growth Factor 7 1Combined Modality Therapy 1Carboplatin 1Bleomycin 1Allovectin-7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Laryngeal Diseases × Pemetrexed × Clear all
NCT01087970 2014-05-19

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Eli Lilly and Company

Phase 2 Completed
69 enrolled 15 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases

NCT01057589 2013-09-18

A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Eli Lilly and Company

Phase 2 Completed
66 enrolled 11 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Diseases, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡